Success Metrics

Clinical Success Rate
93.9%

Based on 108 completed trials

Completion Rate
94%(108/115)
Active Trials
18(12%)
Results Posted
51%(55 trials)
Terminated
7(5%)

Phase Distribution

Ph phase_1
36
24%
Ph early_phase_1
1
1%
Ph phase_2
37
25%
Ph phase_4
9
6%
Ph not_applicable
31
21%
Ph phase_3
36
24%

Phase Distribution

37

Early Stage

37

Mid Stage

45

Late Stage

Phase Distribution150 total trials
Early Phase 1First-in-human
1(0.7%)
Phase 1Safety & dosage
36(24.0%)
Phase 2Efficacy & side effects
37(24.7%)
Phase 3Large-scale testing
36(24.0%)
Phase 4Post-market surveillance
9(6.0%)
N/ANon-phased studies
31(20.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.3%

108 of 117 finished

Non-Completion Rate

7.7%

9 ended early

Currently Active

18

trials recruiting

Total Trials

150

all time

Status Distribution
Active(19)
Completed(108)
Terminated(9)
Other(14)

Detailed Status

Completed108
unknown14
Recruiting12
Terminated7
Active, not recruiting6
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
150
Active
18
Success Rate
93.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.7%)
Phase 136 (24.0%)
Phase 237 (24.7%)
Phase 336 (24.0%)
Phase 49 (6.0%)
N/A31 (20.7%)

Trials by Status

recruiting128%
unknown149%
not_yet_recruiting11%
withdrawn21%
active_not_recruiting64%
terminated75%
completed10872%

Recent Activity

Clinical Trials (150)

Showing 20 of 150 trialsScroll for more
NCT06762964Phase 2

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

Recruiting
NCT05781399Phase 1

First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

Completed
NCT05714085Phase 2

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Recruiting
NCT07300189Phase 1

A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

Recruiting
NCT06141473Phase 3

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting
NCT03941808Not Applicable

Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo.

Completed
NCT00856947Phase 1

Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood

Active Not Recruiting
NCT06366464Phase 3

A Study of Pitolisant in Patients With Prader-Willi Syndrome

Recruiting
NCT05658575Phase 2

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Recruiting
NCT06727396Phase 1

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

Completed
NCT05259046Not Applicable

The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health

Active Not Recruiting
NCT02162849Phase 4

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

Active Not Recruiting
NCT04804241Phase 2

Senicapoc in Alzheimer's Disease

Recruiting
NCT07314242Phase 2

A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD

Not Yet Recruiting
NCT04332068Phase 2

Ivermectin Safety in Small Children

Completed
NCT05822544Phase 1

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Recruiting
NCT05651503Not Applicable

The Effect of Oral Probiotics on Oral Hygiene and Halitosis in Orthodontic Patients.

Completed
NCT07112274Not Applicable

Empagliflozin on Patients With Preserved Heart Failure

Completed
NCT04701034Phase 2

Intravenous Immunoglobulin and Prednisolone for RPL After ART.

Completed
NCT06017999Phase 2

XG005 for Pain Control in Subjects Undergoing Bunionectomy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
150